-
SynapDx Corporation Timeline | Circa 2010 – 2017 #NotAnAutisticAlly #AutisticHistory
About SynapDx Corp. “SynapDx is a private company providing laboratory diagnostics to physicians who suspect children of developmental disorders, with the initial goal of enabling earlier detection of autism spectrum disorders (ASDs). The company collaborates with ASD and gene expression experts at leading institutions, including Boston Children’s Hospital. SynapDx was founded 2010 and is based in…
-
Archived | Google-backed autism diagnostic firm SynapDx shuts down & More | Circa May 11, 2017 #AutisticHistory
Google-backed autism diagnostic firm SynapDx shuts down By Max Stendahl – Digital Editor, Boston Business Journal May 11, 2017, 1:25pm EDT “One of the risks of biotech companies is that sometimes you have a hypothesis, and nature just disagrees with you. That’s what happened here,” said GV’s Krishna Yeshwant. Read article here >> SynapDX is listed out of…
-
Archived | SynapDx Corporation Secures $15.4M in Funding Led by Google Ventures | Circa July 22, 2013 #NotAnAutisticAlly #AutisticHistory
SynapDx Corporation Secures $15.4M in Funding Led by Google Ventures Investment Propels Development of SynapDx’s Innovative Blood Test for the Early Diagnosis of AutismJuly 22, 2013 09:00 AM Eastern Daylight Time LEXINGTON, Mass.–(BUSINESS WIRE)–SynapDx Corporation, today announced it has secured a $15.4 million funding round, led by Google Ventures. Foundation Medical Partners also joined the financing as a…
-
Archived | Kraft Group backs autism test startup SynapDx, 3rd funding for firm since Dec. | Circa May 27, 2013 #NotAnAutisticAlly
Kraft Group backs autism test startup SynapDx, 3rd funding for firm since Dec. By Kyle Alspach – Technology Editor, Boston Business Journal Mar 27, 2013, 10:28am EDT The Kraft Group, owner of the New England Patriots and numerous other businesses, has made a “significant investment” into Southborough-based SynapDx, which is developing an early detection blood-based test for autism spectrum…
-
Archived | Autism test maker secures $9m | Circa June 2, 2010
Autism test maker secures $9m Globe Staff / June 2, 2010 SynapDx Corp., a new Waltham company that aims to develop tests for the early detection of autism, yesterday announced the completion of a $9 million round of financing. Investing were Bain Capital Ventures, General Catalyst Partners, and North Bridge Venture Partners. “Autism has a profound effect…
-
Archived | Featured Startup Pitch: Backed by some prominent investors, SynapDx is developing a test for significantly earlier Autism detection in children | Circa July 12, 2013 #NotAnAutisticAlly
Featured Startup Pitch: Backed by some prominent investors, SynapDx is developing a test for significantly earlier Autism detection in children July 12, 2013 StartUp BeatTM/ BRK Media, LLC. Company: SynapDx Corporation Website: www.synapdx.com Video: Headquarters: Lexington, Massachusetts Year Founded: 2010 Founders: Stanley Lapidus (President), Jeffrey Luber (VP, Corporate Development) Employees: 18 Investors: North Bridge Venture Partners, General Catalyst Partners, Laboratory Corporation of America, The Kraft…
-
Archived | SynapDx Corporation’s CEO Stanley Lapidus Presents at Autism Speaks’ Inaugural Autism Investment Conference | Circa February 21, 2013 #NotAnAutisticAlly
FOR IMMEDIATE RELEASE SynapDx Corporation’s CEO Stanley Lapidus Presents at Inaugural Autism Investment Conference Discusses Diagnostic Issues at Event Hosted by Autism Speaks Lexington, MA – February 21, 2013 – SynapDx Corporation is joining a select group of autism-focused companies to present at the inaugural Autism Investment Conference, held today in New York, NY and…
International Badass Activists 